Nuveen’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$74.6M Sell
1,165,068
-47,480
-4% -$3.12M 0.02% 515
2026
Q1
$86.3M Buy
1,212,548
+259,003
+27% +$20.4M 0.02% 441
2025
Q4
$78.2M Sell
953,545
-15,884
-2% -$1.24M 0.02% 470
2025
Q3
$72.8M Sell
969,429
-51,443
-5% -$3.84M 0.02% 495
2025
Q2
$75.6M Buy
1,020,872
+66,124
+7% +$4.6M 0.02% 468
2025
Q1
$77.1M Buy
954,748
+31,868
+3% +$2.74M 0.02% 473
2024
Q4
$72.2M Sell
922,880
-4,998
-0.5% -$425K 0.02% 500
2024
Q3
$87.1M Sell
927,878
-263,467
-22% -$22.1M 0.02% 458
2024
Q2
$92.8M Buy
1,191,345
+243,977
+26% +$19.9M 0.03% 425
2024
Q1
$86.1M Sell
947,368
-203,297
-18% -$16.9M 0.03% 456
2023
Q4
$89M Sell
1,150,665
-106,116
-8% -$7.43M 0.03% 433
2023
Q3
$85.5M Sell
1,256,781
-126,340
-9% -$9.19M 0.03% 409
2023
Q2
$112M Buy
1,383,121
+142,216
+11% +$11.3M 0.04% 356
2023
Q1
$102M Buy
+1,240,905
New +$88.6M 0.04% 362

Other funds holding GEHC

Nuveen's GEHC Position: Q2 2026 in Review

Nuveen reduced its GE HealthCare (GEHC) stake by 3.9% in Q2 2026, selling an estimated $3.12M and leaving 1,165,068 shares worth $74.6M. The position accounts for 0.02% of the portfolio, ranked #515.

Nuveen first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $112M in Q2 2023. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Nuveen held 1,165,068 shares of GE HealthCare worth $74.6M as of Q2 2026.
  • Nuveen sold 47,480 GE HealthCare shares in Q2 2026, an estimated $3.12M.
  • GE HealthCare made up 0.02% of Nuveen's portfolio in Q2 2026, its #515 holding.
  • Nuveen first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Nuveen's GE HealthCare position peaked at $112M in Q2 2023.
  • 1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.